Share.Market Logo

Anthem Biosciences Limited

  • Minimum Investment
    ₹14,040
  • Price Range
    ₹540 - ₹570
  • Issue Size
    ₹3,395.00 Cr
  • Lot Size
    26 shares

Proceeds of this IPO to be used for

To carry out the offer for sale of equity shares of face value of Rs 2 each by the selling shareholders aggregating up to Rs 3,395 crore

Achieve the benefits of listing equity shares on the stock exchanges

Download RHP DocumentGet more in-depth details about this IPO.

Strengths & Weaknesses of Anthem Biosciences Limited

Automated manufacturing infrastructure

The company operates two CGMP (current good manufacturing practice)--compliant manufacturing facilities in India (Units I and II) with a combined annual custom synthesis capacity of 270 kL and fermentation capacity of 142 kL. The fermentation capacity is the largest among all assessed Indian CRDMO companies, according to the F&S Report

Tailored business model

The company follows a differentiated business model that caters to the needs of small pharmaceutical and emerging biotech companies, offering integrated services from drug discovery to commercial manufacturing. This model supports these companies in overcoming challenges related to funding, technical expertise, and manufacturing scalability

Innovation focused

The company’s innovation-focused approach allows it to offer a wide range of technologically advanced solutions across various modalities and manufacturing practices. This enables them to stay ahead in the competitive landscape and meet diverse client needs effectively

Inability to develop or improve technologies

Failure to develop new technologies or improve existing ones may adversely affect the company's competitive position, potentially leading to a material impact on its business, financial condition, and results of operations

Periodic inspections & audits

Failure to obtain required approvals from regulatory authorities and customers in a timely manner could negatively impact the company's business, operations, financial condition, and cash flows

Risk of accidents

The company faces risks of loss due to fire, accidents, and other hazards, as its R&D and manufacturing processes involve flammable and hazardous materials. Any interruptions or delays in manufacturing could impact customer demand and harm business, financial condition, and operations

Financials

Earnings Per Share

Earnings Per Share (EPS) is calculated by dividing a company’s net income by its average number of outstanding shares.

No Data

Balance Sheet

A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Particulars (In Cr)Y/Y Change
Total Current Assets--
Total Non-Current Assets--
Fixed assets--
Total assets--
Total Current Liabilities--
Total Non-Current Liabilities--
Total Capital Plus Liabilities--
Total Shareholder Funds--
Total Debt to Equity--

Cash Flow

The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Particulars (In Cr)Y/Y Change
Cash from Operating Activity--
Cash from Financing Activities--
Cash from Investing Activities--
Net Cash Flow--

About Anthem Biosciences Limited

Anthem Biosciences was incorporated on June 13, 2006. The company is an innovation-driven, technology-focused Contract Research, Development, and Manufacturing Organization (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing. It is one of the few in India with capabilities in New Chemical Entity (NCE) and New Biological Entity (NBE) across these stages
  • Promoter
    Ajay Bhardwaj
  • Promoter
    Ishaan Bhardwaj
  • Promoter
    Ganesh Sambasivam
  • Promoter
    K Ravindra Chandrappa

Anthem Biosciences Limited IPO FAQs

What is Anthem Biosciences Limited IPO?

down-arrow
Anthem Biosciences Limited IPO refers to the initial public offering of shares by Anthem Biosciences Limited. It is a process by which the company offers its shares to the public for the first time, allowing individuals to become shareholders.

What is the issue size of Anthem Biosciences Limited IPO?

down-arrow
For Anthem Biosciences Limited IPO the issue size is ₹3,395 Cr. The issue size is the total value of the shares offered to the public. It represents the amount the company aims to raise through the IPO.

What is the minimum investment amount for the Anthem Biosciences Limited IPO?

down-arrow
For Anthem Biosciences Limited IPO the minimum investment is ₹14,040. The minimum investment for Anthem Biosciences Limited IPO is the smallest amount an individual can invest to participate in the offering. It is usually determined by the company and regulatory requirements.

What is the lot size of Anthem Biosciences Limited IPO?

down-arrow
For Anthem Biosciences Limited IPO the lot size is 26 shares. The lot size of Anthem Biosciences Limited IPO refers to the number of shares that investors need to bid for and purchase in a single transaction. It is predetermined by the company and regulators.

How to apply for Anthem Biosciences Limited IPO on Share.Market?

down-arrow
To apply for Anthem Biosciences Limited IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the Anthem Biosciences Limited IPO from the list and click on apply now. Place your bids or choose the Cut-off Price option. Enter your UPI ID and set up your mandate to place your application.

Can I pre-apply for Anthem Biosciences Limited IPO?

down-arrow
Yes, investors can often pre-apply for some of the IPOs. Pre-application allows individuals to express their interest in participating in the IPO before the official subscription period begins. To pre- apply for Anthem Biosciences Limited IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the IPO from the list and click on pre-apply now. Once the IPO opens for subscription you can enter your UPI ID and set up your mandate to place your application.

How many days is the IPO application window open?

down-arrow
The IPO application window typically remains open for 3 days, starting from the date of the IPO opening. However, this duration can vary depending on the specific IPO and the regulatory requirements.

Till what time can I apply for an IPO on the last day on Share.Market?

down-arrow
You can apply for the IPO till 3 PM on the last day of application on Share.Market.

What is the allotment date of Anthem Biosciences Limited IPO?

down-arrow
For Anthem Biosciences Limited IPO the allotment date is July 17, 2025. The allotment date of Anthem Biosciences Limited IPO is the date on which shares are allocated to the successful bidders. It marks the distribution of shares to investors.

What are the open and close dates of Anthem Biosciences Limited IPO?

down-arrow
For Anthem Biosciences Limited IPO, the subscription opens on July 14, 2025 and closes on July 16, 2025. The open and close dates of an IPO indicate the period during which investors can submit their bids to participate in the offering.
Bidding Ongoing
-
Total Subscription
63.85x Oversubscribed
Trade
Bidding Ongoing
-
Total Subscription
63.85x Oversubscribed
Trade